{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:39:40Z","timestamp":1790631580026,"version":"4.1.0"},"reference-count":16,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPR"],"DOI":"10.2147\/jpr.s526851","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T14:45:14Z","timestamp":1749134714000},"page":"2805-2808","source":"Crossref","is-referenced-by-count":13,"title":["Suzetrigine Approval Breaks a 25-Year Silence: A New Era in Non-Opioid Acute Pain Management"],"prefix":"10.2147","volume":"Volume 18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2226-3883","authenticated-orcid":true,"given":"Olivier","family":"Sibomana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2533-6785","authenticated-orcid":true,"given":"Melody","family":"Okereke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-5508","authenticated-orcid":true,"given":"Clyde","family":"Hakayuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0304-3959(00)00361-4","volume":"89","author":"M\u00e4ntyselk\u00e4","year":"2001","journal-title":"Pain"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/jocn.13094","volume":"25","author":"Gregory","year":"2016","journal-title":"J Clin Nurs"},{"key":"ref3","unstructured":"IASP. IASP Announces Revised Definition of Pain, International Association for the Study of Pain (IASP). Available from: https:\/\/www.iasp-pain.org\/publications\/iasp-news\/iasp-announces-revised-definition-of-pain\/. Accessed Feb 02, 2025."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40122-020-00217-w","volume":"9","author":"Bonezzi","year":"2020","journal-title":"Pain Ther"},{"key":"ref5","unstructured":"IASP. Acute Pain, International Association for the Study of Pain (IASP). 2025. Available from: https:\/\/www.iasp-pain.org\/resources\/topics\/acute-pain\/. Accessed Feb 02, 2025."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2147\/JPR.S303186","volume":"14","author":"Raffaeli","year":"2021","journal-title":"J Pain Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.2147\/IJGM.S419239","volume":"16","author":"Alorfi","year":"2023","journal-title":"Int J Gen Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/IJICMR.S10200","volume":"3","author":"Pountos","year":"2011","journal-title":"Int J Interferon Cytokine and Mediator Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2049463712438493","volume":"6","author":"Pathan","year":"2012","journal-title":"Br J Pain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1049909111410298","volume":"28","author":"Khan","year":"2011","journal-title":"Am J Hosp Palliat Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2165\/11630080-000000000-00000","volume":"32","author":"Labianca","year":"2012","journal-title":"Clin Drug Investig"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/ph14111091","volume":"14","author":"Paul","year":"2021","journal-title":"Pharmaceuticals"},{"key":"ref13","unstructured":"FDA. FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-novel-non-opioid-treatment-moderate-severe-acute-pain. Accessed Feb 02, 2025."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40122-024-00697-0","volume":"14","author":"Osteen","year":"2025","journal-title":"Pain Ther"},{"key":"ref15","unstructured":"Neurology Live. FDA Approves Vertex Pharmaceuticals\u2019 Suzetrigine for Acute Pain Management, Neurology live. Available from: https:\/\/www.neurologylive.com\/view\/fda-approves-vertex-pharmaceuticals-suzetrigine-acute-pain-management. Accessed Feb 02, 2025."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nn.3602","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat Neurosci"}],"container-title":["Journal of Pain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/103634","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/103634","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T14:45:15Z","timestamp":1749134715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/suzetrigine-approval-breaks-a-25-year-silence-a-new-era-in-non-opioid--peer-reviewed-fulltext-article-JPR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":16,"URL":"https:\/\/doi.org\/10.2147\/jpr.s526851","relation":{},"ISSN":["1178-7090"],"issn-type":[{"value":"1178-7090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}